November 17, 2016 - By Louis Casey · 0 Comments
Cas Medical Systems Inc (NASDAQ:CASM) institutional sentiment decreased to 1.14 in 2016 Q2. Its down -1.19, from 2.33 in 2016Q1. The ratio is negative, as 8 investment professionals started new and increased stock positions, while 7 cut down and sold their stakes in Cas Medical Systems Inc. The investment professionals in our partner’s database now have: 8.79 million shares, down from 9.89 million shares in 2016Q1. Also, the number of investment professionals holding Cas Medical Systems Inc in their top 10 stock positions increased from 0 to 1 for an increase of 1. Sold All: 3 Reduced: 4 Increased: 5 New Position: 3.
CAS Medical Systems, Inc. is a medical technology firm that develops, makes and markets non-invasive patient monitoring products for patient care. The company has a market cap of $46.08 million. The Firm designs, makes and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. It currently has negative earnings. It also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales.
About 81,656 shares traded hands or 195.46% up from the average. CAS Medical Systems Inc (NASDAQ:CASM) has declined 12.82% since April 15, 2016 and is downtrending. It has underperformed by 17.44% the S&P500.
According to Zacks Investment Research, “CAS Medical Systems, Inc. develops and manufactures high-quality blood pressure measurement devices, vital signs monitors, apnea monitors and neonatal supplies that are the first choice of health care professionals around the world. CAS has earned a reputation for providing innovative, reliable products and backing them up with expert technical support. It works closely with health care providers to significantly improve the quality of patient care.”
Acuta Capital Partners Llc holds 3.1% of its portfolio in CAS Medical Systems Inc for 3.50 million shares. Deerfield Management Co owns 3.20 million shares or 0.23% of their US portfolio. Moreover, Broadfin Capital Llc has 0.15% invested in the company for 810,852 shares. The Wisconsin-based 1492 Capital Management Llc has invested 0.12% in the stock. Penbrook Management Llc, a New York-based fund reported 46,800 shares.#img1#
CAS Medical Systems, Inc., incorporated on December 5, 1984, is a medical technology firm that develops, makes and markets non-invasive patient monitoring products for patient care. The Firm designs, makes and distributes the FORE-SIGHT and FORE-SIGHT ELITE brand tissue oximeters and sensors. The Firm also sells various legacy products called Traditional Monitoring, which includes non-invasive blood pressure measurement technologies, neonatal medical disposables and service sales. The Firm operates through two categories of sales: Tissue Oximetry Monitoring and Traditional Monitoring. Tissue Oximetry Monitoring includes sales of its FORE-SIGHT tissue oximeter monitors, sensors and accessories. Traditional Monitoring includes sales of the Company’s legacy products comprising the original equipment maker (OEM) sales of its non-invasive blood pressure technology (MAXNIBP and MAXIQ), and monitor service and repair.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
By Louis Casey